Growth Metrics

Insight Molecular Diagnostics (IMDX) Non-Current Deferred Tax Liability (2020 - 2023)

Historic Non-Current Deferred Tax Liability for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q3 2023 value amounting to $2.2 million.